Jonathan David Schwartz - Nov 18, 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Chief Science & Gene Therapy Officer
Signature
/s/ Martin Wilson, as attorney-in-fact for Jonathan David Schwartz
Stock symbol
RCKT
Transactions as of
Nov 18, 2025
Transactions value $
-$7,592
Form type
4
Date filed
11/20/2025, 04:05 PM
Previous filing
Sep 9, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schwartz Jonathan David Chief Science & Gene Therapy Officer C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Wilson, as attorney-in-fact for Jonathan David Schwartz 2025-11-20 0001726398

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale -$7.59K -2.55K -0.84% $2.98 299K Nov 18, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.

Remarks:

Chief Science & Gene Therapy Officer